Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge
Rena D. Astronomo(Fred Hutch Cancer Center), M. Juliana McElrath(Fred Hutch Cancer Center), Kelly E. Seaton(International Vaccine Institute), Hong‐Van Tieu(New York Blood Center), Nicole Grunenberg(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Kenneth H. Mayer(Miriam Hospital), Julie Czartoski(Fred Hutch Cancer Center), Christina Ochsenbauer(University of Alabama at Birmingham), Georgia D. Tomaras(National Institutes of Health), Maria P. Lemos(University of Pennsylvania), Yiwen Lu(Fred Hutch Cancer Center), Sandeep Narpala(National Institutes of Health), Ian Frank(Norwegian Womens Public Health Association), Katharine Westerberg(Fred Hutch Cancer Center), Julie E. Ledgerwood(Vaccine Research Institute of San Diego), Mary K. Gross(Fred Hutch Cancer Center), Madhu Prabhakaran(National Institutes of Health), Lindsey R. Baden(Brigham and Women's Hospital), Lily Zhang(Fred Hutch Cancer Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Adrian B. McDermott, Scott Hammer(Harvard University Press), Lamar Ballweber-Fleming(Fred Hutch Cancer Center)
Cited by 24
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k